Before you read about Covid-19 vaccine during pregnancy in United States, we recommend you see our overview on Covid-19 vaccination during pregnancy here…
Some states list pregnancy as a high-risk condition that qualifies people to receive COVID-19 vaccines. In New York, pregnant people were included in Phase 1b of vaccine rollout, which began February 15. Illinois has also opened up its eligibility criteria to include pregnant people on February 25, and other states, such as Mississippi, listed pregnancy as a qualifying condition Phase 1b in early February.
CDC vaccine safety report
The Centers for Disease Control and Prevention’s latest vaccine safety report, published March 1, says over 30,000 vaccinated women have reported pregnancies. According to the CDC, pregnant vaccinated women have not reported different or more severe side effects compared to non-pregnant women who received a COVID-19 vaccine. The agency said there has not been an uptick in pregnancy-related complications, like stillbirth and miscarriage — the rate remains the same for all pregnant women, whether they got a vaccine or not.
On February 18, Pfizer-BioNTech started the first and only clinical trial in pregnant women for the COVID-19 vaccine. They aimed to enroll 4,000 participants who are 24 to 34 weeks pregnant.
While we wait for the trial data, it’s largely up to pregnant people who are eligible for the vaccines to decide for themselves if they want to get the shot.
Here is a list of country-wise guidance on which vaccines are being administered and what is the official stance around vaccination for pregnant women: